Reichman University Hosts "Frontiers in Synthetic Biology and Bioconvergence” conference

Last week, Reichman University hosted the “Frontiers in Synthetic Biology and Bioconvergence” conference, initiated by the Scojen Institute for Synthetic Biology in collaboration with the Israeli Society for Synthetic Biology.

This year’s conference explored diverse aspects of synthetic biology and bioconvergence, highlighting the broad impact of these fields — from biological systems engineering for food and health, to bioinductive and sustainable materials, to groundbreaking medical developments.

The event brought together leading researchers and experts from Israel and around the

world, representing a variety of universities and research institutes.

Key topics discussed at the conference included:

- Bioconvergence and Biotechnology Across Scales

Presentations on embryonic models for biomedical research and cultured meat, the development of novel probiotic systems, and the integration of photosynthetic materials in construction.

- Keynote Lecture

A lecture delivered by Prof. Thomas K. Wood focused on the conversion of methane into sustainable energy sources such as acetate, lactate, hydrogen, and electricity.

- Panel Discussion

A high-level dialogue between academic and industrial leaders on the infrastructure required to advance the synthetic biology sector in Israel.

- Synthetic Biology Innovation for Medical Research 

Insights into the use of synthetic DNA libraries, engineered biomolecular condensates,

advanced peptide materials for therapeutic purposes, and applications of synthetic biology in cancer research.

- SynBio Pioneers

Cutting-edge research on artificial cell engineering, innovative environmental sensors, and advancements in computational biology.

- Frontiers in SynBio

A dedicated session spotlighting the younger generation of researchers in the field — postdocs and recent graduates — who presented innovative research in genetic systems engineering, cellular regulations, and bacterial defense mechanisms.

The conference reflected the growing strength and momentum of synthetic biology in Israel, the ever-expanding collaborations between academia and industry, and the field’s vital contribution to the future of science, medicine, and emerging industries.